Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 16. April 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8877  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 177534  
   
Treatments on the Horizon for Men with Advanced Prostate Cancer.
Urol Clin North Am
Ehrlich MI, Gejman RS, Bernstein E, Stein MN.
PMID: 41986027 [PubMed - indexed for MEDLINE]


Systemic Treatments of Castration-Resistant Prostate Cancer.
Urol Clin North Am
Desai AN, Fleyshman M, Lall N, Saraiya B.
PMID: 41986026 [PubMed - indexed for MEDLINE]


Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer.
Urol Clin North Am
Lluís D, Cheng W, Piulats JM, Heras L, Aytes Á, Kruithof de Julio M.
PMID: 41986025 [PubMed - indexed for MEDLINE]


Radiotherapy in Men with De Novo Metastatic Prostate Cancer.
Urol Clin North Am
Messing I, Rao YJ, Goyal S.
PMID: 41986024 [PubMed - indexed for MEDLINE]


Cytoreductive Radical Prostatectomy in Men with De Novo Metastatic Prostate Cancer.
Urol Clin North Am
Ragam R, Chua KJ, Wei J, Aron M.
PMID: 41986023 [PubMed - indexed for MEDLINE]


Systemic Treatments in Men with De Novo Metastatic Prostate Cancer.
Urol Clin North Am
Lim DH, Zhang A, Kim IY.
PMID: 41986022 [PubMed - indexed for MEDLINE]


Managing Prostate Cancer Biochemical Recurrence after Definitive Local Therapy.
Urol Clin North Am
Winograd J, Suzman E, Wang S, Hu JC.
PMID: 41986021 [PubMed - indexed for MEDLINE]


Managing Clinical N1 Prostate Cancer.
Urol Clin North Am
Imam S, Yuh B.
PMID: 41986020 [PubMed - indexed for MEDLINE]


Neoadjuvant and Adjuvant Therapies for High-Risk Prostate Cancer.
Urol Clin North Am
Penukonda S, Hyams E, Pareek G, Santopietro A, Carneiro B.
PMID: 41986019 [PubMed - indexed for MEDLINE]


Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma.
Urol Clin North Am
Shen J, An Y.
PMID: 41986018 [PubMed - indexed for MEDLINE]


Role of Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer: Should It be Done?
Urol Clin North Am
Elkun Y, Gupta R, De Almeida Luz M, Tewari AK.
PMID: 41986017 [PubMed - indexed for MEDLINE]


Surgical Management of High-Risk Prostate Cancer.
Urol Clin North Am
Cheaib JG, Allaf ME.
PMID: 41986016 [PubMed - indexed for MEDLINE]


Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches.
Urol Clin North Am
Ajjawi I, Sprenkle PC, Renzulli JF, Leapman MS.
PMID: 41986015 [PubMed - indexed for MEDLINE]


High Risk Prostate Cancer: What is it?
Urol Clin North Am
Fu MZ, Golombos D, Ghodoussipour S.
PMID: 41986014 [PubMed - indexed for MEDLINE]


Comparative Performance of Prostate Cancer Risk Prediction Tools in Gay, Bisexual, and Other Men Who Have Sex with Men Versus Heterosexual Men.
Urology
Fink KE, Liu Y, Wiarda G, Gowda A, Chan D, Neill C, Silberman P, Amarasekera C, Patel HD, Ross AE, Sun Z, Murphy AB.
PMID: 41985632 [PubMed - as supplied by publisher]


Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients.
Transl Oncol
Zhu L, Liu Y, Lan J, Cai E, Sun D, Liu J, Zong L, Cong Z.
PMID: 41985320 [PubMed - as supplied by publisher]


Mapping Radiotherapy Resources for Prostate Cancer Trials in Nigeria: A STAMPEDE 2-Site Survey.
JCO Glob Oncol
Fatiregun O, Lasebikan N, Ekeke O, Malami A, Gombe A, Sowunmi A, Olatunji-Agunbiade T, Balogun B, Borisade B, Sunday A, Tannock I, James N.
PMID: 41985120 [PubMed - indexed for MEDLINE]


Evaluating the correlation between biopsy frequency and reduced sexual function in prostate cancer patients under active surveillance: a prospective cohort study.
J Sex Med
Angulo-Llanos L, Cortizas EM, Williams AD, Howell NB, Guerard T, Punnen S, Masterson TA, Kava B.
PMID: 41985042 [PubMed - indexed for MEDLINE]


Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.
JAMA Netw Open
Zarba M, Saad E, Semaan K, El Zarif T, Ferrier E, Wells C, El Hajj Chehade R, Basappa NS, Ebrahimi H, Huseni M, Banchereau R, McKay RR, Wood L, Beuselinck B, Suárez C, Takemura K, Lalani AA, Li H, Spain LA, Templeton AJ, Powles TB, Bjarnason GA, de Velasco G, Choueiri TK, Heng DYC.
PMID: 41984479 [PubMed - indexed for MEDLINE]


A multi-paradigm evaluation spanning pixels to voxels for deep learning-based kidney tumor segmentation.
J Med Eng Technol
Lalwani R, Telang A, Tiwari V.
PMID: 41984454 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 177534    Seite 1 von 8877  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1